Endothelin as a local regulating factor in the bovine oviduct by Yamamoto, Yuki et al.
 1 
Endothelin as a local regulating factor in the bovine oviduct 
 
 
Yuki YamamotoA, Misa KohkaA, Yoshihiko KobayashiA, Izabela Woclawek-PotockaB and Kiyoshi 
OkudaAC 
 
A Laboratory of Reproductive Physiology, Graduate School of Environmental and Life Science, Okayama 
University, 1-1-1 Tsushimanaka, Kita-ku, Okayama, Okayama, 700-8530, Japan 
B Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food 
Research, Polish Academy of Sciences, 10–747 Olsztyn, Poland 
CCorresponding Author: kokuda@cc.okayama-u.ac.jp 
 
Running head: Endothelin system in the bovine oviduct 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Abstract 
 Endothelin (EDN) is a possible regulating factor of oviductal motility, which is important for the 
transport of gametes and embryo. To clarify the factors that control the secretion of EDN in the bovine 
oviduct, the expressions of EDNs, EDN-converting enzymes (ECEs) and EDN receptors (EDNRs) were 
investigated. 
 All isoforms of EDN (EDN1-3), ECE (ECE1 and ECE2) and EDNR (EDNRA and EDNRB) were 
immunolocalized in the epithelial cells of the ampulla and the isthmus. EDNRs were also 
immunolocalized in the smooth muscle cells. The mRNA expressions of EDN2 and ECE2 were higher in 
the cultured ampullary oviductal epithelial cells than in the isthmic cells. The expressions of EDN1, EDN2 
and ECE2 in the ampullary tissue were highest on the day of ovulation. Estradiol-17β increased EDN2 and 
ECE1 expressions, while progesterone increased only ECE1 expression in the cultured ampullary 
epithelial cells. These results indicate that EDNs are produced by the epithelial cells and their target site is 
the smooth muscle and the epithelial cells, and suggest that ovarian steroids are regulators of endothelin 
synthesis in ampullary oviductal epithelial cells.  
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Introduction 
 Endothelin (EDN) participates in various biological processes in the reproductive system including 
luteolysis (Acosta et al. 2007), contraction of myometrium (Kozuka et al. 1989) and rupture of the follicle 
(Bridges et al. 2011) in several mammalian species, although it was originally found as a vasoactive 
peptide (Yanagisawa et al. 1988). EDN1, EDN2 and EDN3 encode prepro-EDN1, prepro-EDN2 and 
prepro-EDN3, respectively (Inoue et al. 1989). These prepro-EDNs and “big-EDNs” which are converted 
from prepro-EDNs are biologically inactive. EDN-converting enzyme (ECE) 1 and ECE2 are required for 
converting big-EDNs to active EDNs (Turner and Murphy 1996). EDN receptor (EDNR) has two 
isoforms, EDNRA and EDNRB (Arai et al. 1990). The binding affinity of EDNRA to EDN1 and EDN2 is 
higher than it is to EDN3, while EDNRB has the equal affinities for the three EDNs (Sakurai et al. 1990).  
For the fertilization to occur and lead to the successful pregnancy establishment, oviductal smooth 
muscle motility is important for the transport of gametes and embryo. Several factors including 
prostaglandins (Siemieniuch et al. 2009), nitric oxide (Rosselli et al. 1994; Szostek et al. 2011) and 
luteinizing hormone (LH) (Wijayagunawardane et al. 1999a; Wijayagunawardane et al. 1999b; Ziecik . 
2007) have been reported to affect oviductal contraction and relaxation. EDN also induces the contraction 
of oviductal smooth muscle in several species (Priyadarsana et al. 2004; Al-Alem et al. 2007; Jankovic et 
al. 2009). EDN1 contracts the oviductal smooth muscle in cow (Wijayagunawardane et al. 2001), and 
EDN2 induces the contraction of oviduct via EDNRA in rats (Al-Alem et al. 2007). In addition, EDN1 
mRNA is expressed in murine (Jeoung et al. 2010), human (Sakamoto et al. 2001) and bovine oviducts 
(Priyadarsana et al. 2004). These previous reports imply that the oviduct contains a para- or autocrine EDN 
system for regulating oviductal motility.  
 To define the EDN system in the bovine oviduct, the production and the target sites of EDNs were 
evaluated in the present study. The effects of ovarian steroids on the expressions of EDNs and ECEs were 
also investigated in vitro.  
 
Materials and Methods 
Collection of bovine oviductal tissues 
Oviducts from Holstein cows were collected at a local abattoir within 10-20 min after exsanguination. 
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The stages of the estrous cycle (ovulation day (OV); Days 2-3 after ovulation, early luteal stage (E); Days 
5-6, developing luteal stage (D); Days 8-12, mid luteal stage (M); Days 15-17, late luteal stage (L); Days 
19-21, follicular stage (F)) were determined based on macroscopic observations of the ovary and the uterus 
(Okuda et al. 1988; Miyamoto et al. 2000). Oviductal tissues ipsilateral to the corpus luteum or the 
dominant follicle were collected at Days 0-3 after ovulation were utilized for immunohistochemistry and 
cell culture, and oviductal tissues at each stage of the estrous cycle for total RNA extraction. 
 
Immunohistochemistry 
The ampullary and isthmic oviductal tissues were fixed with 4% paraformaldehyde phosphate buffer 
solution and embedded in paraffin. The paraffin–embedded tissues were sectioned (6 μm) and placed on 
silane coated slide glasses (S3003, Dako A/S, Glostrup, Denmark). The serial sections were prepared and 
used for the immunohistochemistry. 
After deparaffinization with xylene, the tissue sections were incubated with 0.3% H2O2 in methanol at 
room temperature for 30 min to quench nonspecific staining. After washing with phosphate buffer saline 
(PBS), the sections were subjected to antigen retrieval by heating in 0.01 M sodium citrate buffer (pH 6.0) 
using microwave at 600 W for 15 min. The sections were then incubated in 10% normal horse serum 
(MP-7500-50, Vector laboratories, Burlingame, CA, U.S.A.) at room temperature for 30 min. Then they 
were incubated at 4°C over night with rabbit anti-Endothelin-1 (T4050, Peninsula Laboratories, LLC., San 
Carlos, CA, U.S.A.), anti-EDN2 rabbit polyclonal (HPA028459, ATLAS Antibodies, Stockholm, Sweden), 
anti-endothelin-3 rabbit polyclonal (H-023-17, Phoenix Pharmaceuticals, Mannheim, Germany), 
anti-ECE1 rabbit polyclonal (HPA013616, ATLAS Antibodies), anti-ECE2 rabbit polyclonal (HPA043346, 
ATLAS Antibodies), anti-endothelin receptor A rabbit polyclonal (NBP1-33614, Novus Biologicals, LLC., 
Littleton, CO, U.S.A.) and anti-endothelin receptor B rabbit polyclonal (NBP1-31108, Novus Biologicals) 
at a dilution of in PBS. After incubation with the antibody, sections were treated with ImmPRESS 
UNIVERSAL Reagent Anti-Mouse/ Rabbit IgG (MP-7500-50, Vector laboratories) at room temperature 
for 30 min. The reaction products were visualized by treating with 0.05% (w/v) 3,3'-diaminobenzidine 
tetrachloride (343-00901, Dojindo, Kumamoto, Japan) containing 0.01% H2O2. Sections were 
counterstained with haematoxylin for 30 sec to better visualize the cell types. Specificity of the antibodies 
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was examined using normal rabbit IgG instead of first antibody.  
 
Total RNA extraction and real-time RT-PCR 
 Total RNA was extracted from oviductal tissues and cells using TRIsure (BIO-38032, Bioline, 
London, UK) according to the manufacturer’s directions. One μg of each total RNA was reverse 
transcribed using iScript RT Supermix for RT-qPCR (170-8841, Bio-Rad Laboratories, Hercules, CA, 
U.S.A.). Quantifications of mRNA expressions were determined by Quantitative RT-PCR using MyiQ 
(Bio-Rad). The reaction mixture contained 10 μl SooAdvanced SYBR Green Supermix (172-5261B05, 
Bio-Rad), 1 μM each forward and reverse primer and 2 ng of reverse-transcribed total RNA as described 
previously (Sakumoto et al. 2006). Nuclease-free water was added up to a total volume of 20 μl. Each 
complementary DNA (cDNA) was analyzed in duplicate. All primers were designed to amplify a product 
as shown in Table 1, and the specificity of each primer set was confirmed by running the PCR products on 
a 2.0% agarose gel stained with ethidium bromide. Protocol conditions were consisted of denaturation at 
95 °C for 3 min, followed by 45 cycles at 94 °C for 15 sec, 60 °C for 20 sec and 72 °C for 15 sec with a 
final dissociation (melting) curve analysis. The most stable transcribed housekeeping gene was identified 
with Normfinder software (download at http://moma.dk/normfinder-software). This software calculates the 
gene expression stability measure (M) and determines the most stable housekeeping gene via a stepwise 
exclusion or ranking process resulting in the selection of the most stable housekeeping genes for the 
specific tissue. The M values of GAPDH, β-actin and 18S rRNA in the bovine oviduct were 0.017, 0.026 
and 0.069, respectively. Thus, GAPDH was used as a housekeeping gene for all experiments. Mean ± 
standard errors of mean (SEM) of CT values were 27.1 ± 0.21 (EDN1), 31.4 ± 0.12 (EDN2), 30.6 ± 0.10 
(EDN3), 28.1 ± 0.12 (ECE1) and 30.6 ± 0.10 (ECE2) in the tissues (n=30), and 28.0 ± 0.37 (EDN1), 27.6 
± 0.81 (EDN2), 28.4 ± 0.58 (EDN3), 28.1 ± 0.22 (ECE1) and 32.8 ± 0.34 (ECE2) in the cultured epithelial 
cells (n=12). To analyze the relative level of expression of each mRNA, the 2-ΔΔCT method was used 
(Livak and Schmittgen 2001). 
 
Isolation and culture of oviductal epithelial cells 
Cells were isolated from 6 oviducts in the present study. Epithelial cells were isolated separately from 
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the ampullary and isthmic sections of the oviduct by perfusion with 20 ml Hank’s balanced salt solution 
(HBSS) as described previously (Kobayashi et al., 2013). HBSS contained 0.25% (wt/vol) bovine trypsin 
(>7500 BAEE units/mg solid; T9201, Sigma-Aldrich, St. Louis, MO, USA), 0.02% (wt/vol) EDTA2Na 
(Sigma-Aldrich), 0.1% (wt/vol) BSA (10735-086001, Roche, Manheim, Germany), 100 IU/ml penicillin 
(611400, Meiji Seika Pharma, Tokyo, Japan) and 100 g/ml streptomycin (6161400, Meiji Seika Pharma). 
HBSS was delivered at flow rate of 10 ml/min, 38 C, for 30 min. The dissociated epithelial cells were 
filtered through metal meshes (150 μm and 77 μm) to remove undissociated tissue fragments. The filtrates 
were washed by centrifugation (180 × g for 10 min at 4 C) with Tris-buffered ammonium chloride (pH 7.5) 
to remove hemocytes, followed by washing with Dulbecco’s Modified Eagle’s Medium (DMEM; D1152, 
Sigma-Aldrich) supplemented with 0.1% (wt/vol) BSA, 100 IU/ml penicillin and 100 μg/ml streptomycin. 
After the washing, the final pellets were resuspended by DF (DMEM/Ham’s F-12; 1:1 (vol/vol) 
(12400-024, Life Technologies, Carlsbad, CA, USA) supplemented with 10% (vol/vol) bovine calf serum 
(16170-078, Life Technologies), 20 mg/ml gentamicin (G1397, Life Technologies) and 2 mg/ml 
amphotericin B (A9528, Sigma-Aldrich)). The cells were seeded at a density of 1.0 × 105 viable cells/ml to 
25-cm2 culture flasks (690160, Greiner Bio-One, Frickenhausen, Germany) and cultured at 38.5 C in a 
humidified atmosphere of 5% CO2 in air. The stromal and epithelial cell culture media were changed every 
48 h for 5-10 days until the cells reached 80-90% confluence. The epithelial cells were trypsinized using 
0.02% porcine trypsin and 0.02% bovine trypsin for purification as described previously (Kobayashi et al., 
2013). The purified epithelial cells were seeded to 24-well plates (662160, Greiner) at a density of 1.0 × 105 
viable cells/ml and incubated at 38.5 C in a humidified atmosphere of 5% CO2 in air. The medium was 
changed every 48 h until the cells reached 90-95% confluence.  
 
Experimental design 
Experiment 1: Immunolocalization of EDNs, ECEs and EDNRs in the bovine oviduct 
 The localization of each factor was detected by immunohistochemistry using the ampullary and the 
isthmic segment of oviduct collected at Day 0-3 after ovulation to define production and target sites of 
EDNs.  
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Experiment 2: EDN and ECE mRNA expressions in the epithelial cells of ampulla and isthmus 
 Since the epithelial cells immediately after isolation were not pure, we used cultured epithelial cells 
to analyze mRNA expressions of EDNs and ECEs in the epithelial cells. The cultured ampullary and 
isthmic oviductal epithelial cells were isolated from 6 cows. After the cells reached 90-95% confluence (< 
7 days after seeding), they were washed by PBS twice followed by culture in fresh DF (DMEM/Ham’s 
F-12; 1:1 (vol/vol) (D2906-10, Sigma-Aldrich)) supplemented with 0.1% BSA (15408, Roche), 500 μM 
ascorbic acid (013-12061, Wako Pure Chemical Industries), 5 μg/ml holo-transferrin (T3400, 
Sigma-Aldrich), 5 μg/ml sodium selenite (S5261, Sigma-Aldrich) and 2 μg/ml insulin (I4011, 
Sigma-Aldrich)) for 4 h incubation. Total RNA was extracted from the cells cultured in 3 wells per oviduct 
and the expressions of EDNs and ECEs were measured by real-time RT-PCR. 
 
Experiment 3: EDN mRNA expressions in oviductal tissues 
 Oviductal tissues were collected from 5 cows at each stage of estrous cycle. The expressions of 
EDNs and ECEs were measured by real-time RT-PCR. 
 
Experiment 4: Effects of estradiol-17ß (E2) and progesterone (P4) on EDN and ECE mRNA expressions in 
ampullary oviductal epithelial cell 
 Since stage-specific differences between the expressions of EDNs and ECEs were not observed in 
the isthmic tissue in Experiment 3, only ampullary cells were investigated in Experiment 4. Cultured 
ampullary oviductal epithelial cells isolated from 6 cows were utilized. After the cells reached 90-95% 
confluence (< 7 days after seeding), the cells were treated with E2 (0.1, 1, 10 nM) and P4 (1, 10, 100 nM) 
in fresh DF as described in Experiment 2. Each treatment was performed in triplicate. After 4 h incubation, 
total RNA was extracted from the cells. The expressions of EDNs, ECEs and EDNRs were measured by 
real-time RT-PCR. 
 
Statistical analyses 
 Outliers were detected by Grubbs' test and removed from each group in all experiments. The 
statistical significance of differences was assessed by t-test for two groups, and by one-way analysis of 
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variance followed by Tukey’s multiple comparisons test for more than three groups. P values less than 0.05 
were considered to be statistically significant.  
 
Results 
Experiment 1: Immunolocalization of EDNs, ECEs and EDNRs in the bovine oviduct 
 Distinct immunolocalization of EDN1, EDN2 and EDN3 were observed in the luminal epithelial 
layer as well as in the smooth muscle layer of both the ampullary and the isthmic sections (Figure 1C-H). 
On the other hand, immunoreactions of ECE1 and ECE2 were observed clearly in the epithelial layer, but 
faintly in the smooth muscle layer in the ampulla and isthmus (Figure 1I-L). Both EDNRA and EDNRB 
were localized in the smooth muscle layer as well as in the epithelium in both the ampulla and isthmus 
(Figure 2). 
 
Experiment 2: EDN and ECE mRNA expressions in cultured epithelial cells of ampulla and isthmus 
 The mRNA expressions of all EDN and ECE isoforms were detected in cultured epithelial cells in 
both ampulla and isthmus of the bovine oviduct (Figure 3). The mRNA expressions of EDN2 (F= 168.1, 
DF=10, P= 0.032; Figure 3B) and ECE2 (F= 9.5, DF=11, P= 0.047; Figure 3B) were significantly higher 
in the ampullary cells than in the isthmic cells. 
 
Experiment 3: EDN mRNA expressions in oviductal tissues  
 The mRNA expression levels of EDNs and ECEs varied among the estrous stages were shown in 
only the ampullary tissue but not in the isthmic tissue. EDN1 expression was significantly higher at the day 
of ovulation than at and the follicular stage in the ampullary tissues (F= 2.7, DF= 21, P=0.037; Figure 4A). 
EDN2 expressions at the day of ovulation were significantly higher than at the early stage (P=0.049), the 
luteal stage (P=0.022) and the follicular stage (P=0.008) (F=4.2, DF=24; Figure 4B). ECE2 expressions 
were significantly higher at the day of ovulation than the follicular stage (F=3.2, DF=21, P=0.013; Figure 
4E).  
 
Experiment 4: Effects of estradiol-17ß (E2) and progesterone (P4) on EDN and ECE mRNA expressions in 
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ampullary oviductal epithelial cell 
 E2 increased both EDNs and ECE in the cultured ampullary epithelial cells. ECE1 (F= 3.4, DF= 5, 
P= 0.03) and EDN2 (F= 3.3, DF= 5, P= 0.045) expressions were significantly stimulated by 1 nM and 10 
nM E2 treatment, respectively (Figure 5). E2 treatment (1 nM) tended to increase EDN1 expression, 
although the increase was not significant (F= 3, DF= 5, P= 0.06; Figure 5). On the other hand, P4 increased 
only ECE1 expression, which was significantly stimulated by 10 nM (F=3.6, DF= 5, P= 0.027; Figure 6) 
P4 treatment.  
 
Discussion 
 The present study demonstrated the presence of all isoforms of EDN, ECE and EDNR in the bovine 
oviduct. This is the first report of EDN2 and EDN3 expressions in the bovine oviduct. EDNs and ECEs 
were localized in epithelial cells of both the ampulla and isthmus. Since ECEs convert big-EDNs to 
bioactive EDNs, the main production site of bioactive EDNs seems to be epithelial cell in the bovine 
oviduct. Despite the presence of immunoreactive EDNs, the immunoreactions of ECEs were faint in the 
smooth muscle layer. Therefore, the smooth muscle layer seems to produce less EDNs than the epithelial 
layer. Since both immunoreactive EDNs and EDNRs were observed, the bovine oviduct may possess a 
local EDN system in which EDNs produced by the epithelial cells act on oviductal smooth muscle via 
EDNR. EDNs produced by the endothelial cells are known to affect the vascular smooth muscle cells via 
EDNRs resulting in vasoconstriction (Kawanabe and Nauli 2011). In addition to its vasoactive effect, 
EDN1 stimulates the contraction of the bovine oviduct (Priyadarsana et al. 2004) and EDN2 also induces 
oviductal contraction in human and rat (Al-Alem et al. 2007; Jankovic et al. 2009). EDNRA activation 
induces the contraction of smooth muscle in several tissues (Al-Alem et al. 2007; Kawanabe and Nauli 
2011), while EDNRB activation induces vasodilation by increasing endothelial NO production (Tsukahara 
et al. 1994; Tykocki et al. 2009). Therefore, EDNRA and EDNRB might have different roles in the bovine 
oviduct, although both seem to be involved in oviductal motility. Additionally, EDNRA has higher 
affinities for EDN1 and EDN2 than EDN3, whereas EDNRB has equal affinities for the three EDNs 
(Sakurai et al. 1990). The oviductal contraction caused by EDN1 (Priyadarsana et al. 2004) and EDN2 
(Al-Alem et al. 2007; Jankovic et al. 2009) might be mainly due to EDNRA activation in the smooth 
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muscle layer. Although it remains uncertain which EDN and EDNR isoforms are dominant in the bovine 
oviduct, our results suggest the presence of a paracrine EDN system for controlling oviductal motility.  
Our results indicate that the syntheses of EDNs and ECEs are regulated by ovarian steroids during 
the estrous cycle in the bovine oviduct. In cultured ampullary epithelial cells, E2 increased EDN2 and 
ECE1 expressions, while P4 stimulated only the expressions of ECE1 in the present study. Ovarian steroids 
regulate the secretory functions of oviductal epithelial cells (Eberhardt et al. 1999; Wijayagunawardane et 
al. 1999a; Wijayagunawardane et al. 1999b). Co-treatment of cultured bovine oviductal epithelial cells 
with E2 and low dose P4 increased EDN1 production but treatment with P4 alone had no effect 
(Wijayagunawardane et al. 1999a). These findings suggest that P4 supports the effect of E2 on EDN 
production by stimulating the syntheses of ECEs. Co-treatment of cultured bovine oviductal epithelial cells 
with high E2 and low P4 level mimicked the hormonal condition at peri-ovulation. This finding, together 
with the finding that the mRNA expressions of EDNRs in the bovine oviduct are high after ovulation 
(Priyadarsana et al. 2004) suggest that EDN system is regulated to be most active around the ovulation. 
Interestingly, in contrast to our results, E2 treatment decreased ECE1 expression in rat vessels (Rodrigo et 
al. 2003) and ECE2 expression in rat brain (Jayaraman et al. 2012). The effects of E2 on ECE expressions 
seem to be specific to each organ. Since ECEs are key enzymes for producing bioactive EDNs, further 
studies are required to determine the roles of EDNs in vivo. 
Because of the structural and the functional differences between the ampulla and the isthmus, each 
EDN might have segment-specific actions in the oviduct. The expressions of EDN2 and ECE2 in cultured 
epithelial cells were higher in the ampulla than in the isthmus in the present study. In addition, differences 
of EDN and ECE mRNA expressions among the estrous stages were observed in only the ampulla. The 
present results demonstrate that immunoreactive EDNRs localize in not only the smooth muscle but also 
the epithelial cells of the bovine oviduct. EDNR localizations in epithelial cells suggest that EDNs play 
some roles in epithelial cell function besides the regulation of smooth muscle motility. Although the 
structures of the three EDNs differ by only several amino acids, each EDN has unique roles in several 
organs (Ling et al. 2013). EDN1 in many kinds of cancer cells affect cellular proliferation and EDN2 is 
involved in immunity (Ling et al. 2013). EDN3 also has been suggested to be involved in fertilization and 
early embryonic development in the murine oviduct (Jeoung et al. 2010). Further studies are needed to 
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understand the roles of EDNs in the bovine oviduct. 
The overall findings of this study indicate that the EDN is produced by oviductal epithelial cells and 
EDNRs localize in the smooth muscle layer, suggesting that the EDN system works to regulate oviductal 
motility for the transport of gametes and the embryo in the bovine oviduct. In addition, ovarian steroids 
may control EDN production through the endocrine system during the estrous cycle. 
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Figure legends 
Figure 1. Micrographs of immunohistochemical staining of endothelin (EDN) 1 (C, D), EDN2 (E, F), 
EDN3 (G, H), endothelin converting enzyme (ECE) 1 (I, J), ECE2 (K, L) and negative control 
(NC; A, B). Serial sections were utilized for the experiments. Left column: Ampullary part, Right 
column: Isthmic part. Open arrowhead: Smooth muscle layer, close arrowhead: Epithelial layer. 
Each scale bar indicates 100 μm. 
 
Figure 2. Micrographs of immunohistochemical staining of endothelin receptor (EDNR) A (C, D), 
EDNRB (E, F) and negative control (NC; A, B). Serial sections were utilized for the experiments. 
Left column: Ampullary part, Right column: Isthmic part. Open arrowhead: Smooth muscle layer, 
close arrowhead: Epithelial layer. Each scale bar indicates 100 μm. 
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Figure 3. Relative expressions of endothelin (EDN) 1 (A), EDN2 (B), EDN3 (C), EDN converting enzyme 
(ECE) 1 (D) and ECE2 (E) mRNA in cultured epithelial cells collected from the ampullary and 
the isthmic oviduct (mean ± SEM, n= 6 oviducts). The statistical significance of differences was 
assessed by t-test. Different superscript letters indicate significant difference (P<0.05). 
 
Figure 4. Relative expressions of endothelin (EDN) 1 (A), EDN2 (B), EDN3 (C), EDN converting enzyme 
(ECE) 1 (D) and ECE2 (E) mRNA in bovine oviduct throughout the estrous cycle (ovulation day: 
OV, Days 2-3 after ovulation: E, Days 5-6: D, Days 8-12: M, Days 15-17: L, Days 19-21: F, mean 
± SEM, n= 5 oviducts per stage). Open bar: Ampullary part, closed bar: Isthmic part. The 
statistical significance of differences was assessed by one-way analysis of variance followed by 
Tukey’s multiple comparison test. Different superscript letters indicate significant difference 
(P<0.05). 
 
Figure 5. Effects of estradiol-17β (E2; 0.1, 1, 10 nM) on mRNA expression of endothelin (EDN) 1 (A), 
EDN2 (B), EDN3 (C), EDN converting enzyme (ECE) 1 (D) and ECE2 (E) in the cultured 
epithelial cells of bovine ampullary oviduct. Results were shown as mean ± SEM, n= 6 oviducts. 
Significant differences were determined by one-way analysis of variance followed by Tukey’s 
multiple comparison test.  
 
Figure 6. Effects of progesterone (P4; 1, 10, 100 nM) on mRNA expression of endothelin (EDN) 1 (A), 
EDN2 (B), EDN3 (C), EDN converting enzyme (ECE) 1 (D) and ECE2 (E) in the cultured 
epithelial cells of bovine ampullary oviduct. Results were shown as mean ± SEM, n= 6 oviducts. 
Significant differences were determined by one-way analysis of variance followed by Tukey’s 
multiple comparison test. 
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